Publications by authors named "Clarke Taylor"

Claim this Profile
M
Moisture-responsive root-branching pathways identified in diverse maize breeding germplasm.
Johannes D Scharwies, Taylor Clarke, Zihao Zheng, Andrea Dinneny, Siri Birkeland

Science· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfation Pathways During Neurodevelopment.
Taylor Clarke, Francesca E Fernandez, Paul A Dawson

Front Mol Biosci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer.
Thomas D Aicher, Chad A Van Huis, Alexander R Hurd, Donald J Skalitzky, Clarke B Taylor

J Med Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity.
Xiao Hu, Xikui Liu, Jacques Moisan, Yahong Wang, Charles A Lesch, Clarke Taylor

Oncoimmunology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Permanent-magnet energy spectrometer for electron beams from radiotherapy accelerators.
David J McLaughlin, Kenneth R Hogstrom, Robert L Carver, John P Gibbons, Polad M Shikhaliev, Taylor Clarke

Med Phys· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease.
Gary D Glick, Rodrigue Rossignol, Costas A Lyssiotis, Daniel Wahl, Charles Lesch, Clarke Taylor

J Pharmacol Exp Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrile.
Manjinder S Lall, Garrett Hoge, Tuan P Tran, William Kissel, Sean T Murphy, Clarke Taylor

J Org Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.
Joseph S Warmus, Cheryl L Quinn, Clarke Taylor, Sean T Murphy, Timothy A Johnson

Bioorg Med Chem Lett· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and structure-activity relationship of 2-morpholino 6-(3-hydroxyphenyl) pyrimidines, a class of potent and selective PI3 kinase inhibitors.
Sabina Pecchi, Paul A Renhowe, Clarke Taylor, Susan Kaufman, Hanne Merritt

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and SAR of benzyl phenyl ethers as inhibitors of bacterial phenylalanyl-tRNA synthetase.
Justin I Montgomery, Peter L Toogood, Kim M Hutchings, Jia Liu, Lakshmi Narasimhan, Clarke Taylor

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors.
Paul A Renhowe, Sabina Pecchi, Cynthia M Shafer, Timothy D Machajewski, Elisa M Jazan, Clarke Taylor

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents.
Sean T Murphy, Heather L Case, Edmund Ellsworth, Susan Hagen, Michael Huband, Clarke Taylor

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and structure-activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases.
Kelly Frazier, Elisa Jazan, Christopher M McBride, Sabina Pecchi, Paul A Renhowe, Clarke Taylor

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis